Environmental Engineering Reference
In-Depth Information
73. Mourtas S, Lazar AN, Markoutsa E, Duyckaerts C, Antimisiaris SG (2014) Multifunctional
nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential
applications for Alzheimer disease. Eur J Med Chem 80:175-183. doi: 10.1016/j.ejmech.
2014.04.050
74. Kaur IP, Kakkar S (2014) Nanotherapy for posterior eye diseases. J Control Release. May
24. pii: S0168-3659(14)00334-4. doi: 10.1016/j.jconrel.2014.05.031 . [Epub ahead of print]
75. Davies LA, Nunez-Alonso GA, McLachlan G, Hyde SC, Gill DR (2014) Aerosol delivery of
DNA/liposomes to the lung for cystic fibrosis gene therapy. Hum Gene Ther Clin Dev.
doi: 10.1089/humc.2014.019
76. Song H, Wang G, He B, Li L, Li C, Lai Y, Xu X, Gu Z (2012) Cationic lipid-coated PEI/DNA
polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesen-
chymal stem cells. Int J Nanomedicine 7:4637-4648
77. Chang TM (2012) From artificial red blood cells, oxygen carriers, and oxygen therapeutics to
artificial cells, nanomedicine, and beyond. Artif Cells Blood Substit Immobil Biotechnol 40
(3):197-199. doi: 10.3109/10731199.2012.662408
78. Chen XA, Zhang LJ, He ZJ, Wang WW, Xu B, Zhong Q, Shuai XT, Yang LQ, Deng YB
(2011) Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for
gene delivery into rat mesenchymal stem cells. Int J Nanomedicine 6:843-853
79. G¨kce M, Kuskonmaz B, Cetin M, Uckan Cetinkaya D, Tuncer M (2013) Coexisting or
underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell
transplant recipients receiving prophylaxis. Exp Clin Transplant 11(5):440-446
80. Ma K, Wang DD, Lin Y, Wang J, Petrenko V, Mao C (2013) Synergetic targeted delivery of
sleeping-beauty transposon system to mesenchymal stem cells using LPD nanoparticles
modified with a phage-displayed targeting peptide. Adv Funct Mater 23(9):1172-1181
81. Kito T, Shibata R, Ishii M, Suzuki H, Himeno T, Kataoka Y, Yamamura Y, Yamamoto T,
Nishio N, Ito S, Numaguchi Y, Tanigawa T, Yamashita JK, Ouchi N, Honda H, Isobe K,
Murohara T (2013) iPS cell sheets created by a novel magnetite tissue engineering method for
reparative angiogenesis. Sci Rep 3:1418. doi: 10.1038/srep01418
82. Liu WH, Liu ZC, You N, Zhang N, Wang T, Gong ZB, Liu HB, Dou KF (2012) Several
important in vitro improvements in the amplification, differentiation and tracing of fetal liver
stem/progenitor cells. PLoS One 7(10):e47346. doi: 10.1371/journal.pone.0047346
83. Palaniyandi K, Pockaj BA, Gendler SJ, Chang XB (2012) Human breast cancer stem cells
have significantly higher rate of clathrin-independent and caveolin-independent endocytosis
than the differentiated breast cancer cells. J Cancer Sci Ther 4(7):214-222
84. D¨ring M, Hartmann U, Erbacher A, Lang P, Handgretinger R, M¨ ller I (2012) Caspofungin
as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell
transplantation: a retrospective analysis. BMC Infect Dis 12:151
85. Gul-Uludag H, Xu P, Marquez-Curtis LA, Xing J, Janowska-Wieczorek A, Chen J (2012)
Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells:
implications
for
clinical
transplantation and gene
therapy. Stem Cells Dev 21
(10):1587-1596. doi: 10.1089/scd.2011.0297
86. Oshikata A, Miyazaki R, Matsushita T, Ueoka R (2011) Selective elimination of the
transformed hepatic stem cells using hybrid liposomes. Yakugaku Zasshi 131(5):757-763
87. Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, Helwani F, Poulton IJ, van
Rooijen N, Alexander KA, Raggatt LJ, L´vesque JP (2010) Bone marrow macrophages
maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood
116(23):4815-4828. doi: 10.1182/blood-2009-11-253534
88. Matsumura Y (2014) The drug discovery by nanomedicine and its clinical experience. Jpn
J Clin Oncol Jun;44(6):515-25. doi: 10.1093/jjco/hyu046 . Epub 2014 Apr 21
89. Nardin A, Lefebvre ML, Labroqu`re K, Faure O, Abastado JP (2006) Liposomal muramyl
tripeptide phosphatidylethanolamine: targeting and activating macrophages for adjuvant
treatment of osteosarcoma. Curr Cancer Drug Targets 6(2):123-133
Search WWH ::




Custom Search